English
简体中文
Total: £ 56.28
Published Date: 2025-02-20 | Pages: 107 | Tables: 103 | Medical Care
The global market for Monoclonal Antibody Development and Production Service was valued at US$ 779 million in the year 2024 and is projected to reach a revised size of US$ 1194 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Monoclonal Antibody Development and Production Service refers to providing service for the development and production of specific monoclonal antibodies (mAbs). Monoclonal antibodies are derived from a single B cell clone and therefore have high specificity and consistency. The production process usually includes antigen design and preparation, immunization of mice or other hosts, B cell fusion, hybridoma screening, clone amplification, antibody purification, and other steps, ultimately obtaining high-purity, high affinity monoclonal antibodies.
North American market for Monoclonal Antibody Development and Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Monoclonal Antibody Development and Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Monoclonal Antibody Development and Production Service in Medical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Monoclonal Antibody Development and Production Service include ThermoFisher, Abcam, BICO, Rockland, ProSci, Biocompare, Bio-Rad, Evitria AG, Capra Science, Innovagen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Development and Production Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Development and Production Service.
The Monoclonal Antibody Development and Production Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibody Development and Production Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoclonal Antibody Development and Production Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ThermoFisher
Abcam
BICO
Rockland
ProSci
Biocompare
Bio-Rad
Evitria AG
Capra Science
Innovagen
Life Science Group
Randox
Davids Biotechnologie
Abgent
InVivo BioTech Services
BioGenes
Helmholtz Zentrum München
Kaneka Eurogentec
Beijing Abace Biology
Beijing Sino Biological
Nanjing GenScript Biotechnology
Shanghai Sangon Biotech
Nanjing Zoonbio Biotechnology
Suzhou Synbio Technologies
Segment by Type
Human Monoclonal Antibodies
Mouse Monoclonal Antibodies
Others
Segment by Application
Medical
Pharmaceutical
Scientific Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Development and Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Development and Production Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human Monoclonal Antibodies
1.2.3 Mouse Monoclonal Antibodies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Development and Production Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Pharmaceutical
1.3.4 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Development and Production Service Market Perspective (2020-2031)
2.2 Global Monoclonal Antibody Development and Production Service Growth Trends by Region
2.2.1 Global Monoclonal Antibody Development and Production Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monoclonal Antibody Development and Production Service Historic Market Size by Region (2020-2025)
2.2.3 Monoclonal Antibody Development and Production Service Forecasted Market Size by Region (2026-2031)
2.3 Monoclonal Antibody Development and Production Service Market Dynamics
2.3.1 Monoclonal Antibody Development and Production Service Industry Trends
2.3.2 Monoclonal Antibody Development and Production Service Market Drivers
2.3.3 Monoclonal Antibody Development and Production Service Market Challenges
2.3.4 Monoclonal Antibody Development and Production Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Development and Production Service Players by Revenue
3.1.1 Global Top Monoclonal Antibody Development and Production Service Players by Revenue (2020-2025)
3.1.2 Global Monoclonal Antibody Development and Production Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Monoclonal Antibody Development and Production Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monoclonal Antibody Development and Production Service Revenue
3.4 Global Monoclonal Antibody Development and Production Service Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Development and Production Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Development and Production Service Revenue in 2024
3.5 Global Key Players of Monoclonal Antibody Development and Production Service Head office and Area Served
3.6 Global Key Players of Monoclonal Antibody Development and Production Service, Product and Application
3.7 Global Key Players of Monoclonal Antibody Development and Production Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Development and Production Service Breakdown Data by Type
4.1 Global Monoclonal Antibody Development and Production Service Historic Market Size by Type (2020-2025)
4.2 Global Monoclonal Antibody Development and Production Service Forecasted Market Size by Type (2026-2031)
5 Monoclonal Antibody Development and Production Service Breakdown Data by Application
5.1 Global Monoclonal Antibody Development and Production Service Historic Market Size by Application (2020-2025)
5.2 Global Monoclonal Antibody Development and Production Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monoclonal Antibody Development and Production Service Market Size (2020-2031)
6.2 North America Monoclonal Antibody Development and Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monoclonal Antibody Development and Production Service Market Size by Country (2020-2025)
6.4 North America Monoclonal Antibody Development and Production Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Development and Production Service Market Size (2020-2031)
7.2 Europe Monoclonal Antibody Development and Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monoclonal Antibody Development and Production Service Market Size by Country (2020-2025)
7.4 Europe Monoclonal Antibody Development and Production Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Development and Production Service Market Size (2020-2031)
8.2 Asia-Pacific Monoclonal Antibody Development and Production Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monoclonal Antibody Development and Production Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Monoclonal Antibody Development and Production Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Development and Production Service Market Size (2020-2031)
9.2 Latin America Monoclonal Antibody Development and Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monoclonal Antibody Development and Production Service Market Size by Country (2020-2025)
9.4 Latin America Monoclonal Antibody Development and Production Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Development and Production Service Market Size (2020-2031)
10.2 Middle East & Africa Monoclonal Antibody Development and Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monoclonal Antibody Development and Production Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Monoclonal Antibody Development and Production Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ThermoFisher
11.1.1 ThermoFisher Company Details
11.1.2 ThermoFisher Business Overview
11.1.3 ThermoFisher Monoclonal Antibody Development and Production Service Introduction
11.1.4 ThermoFisher Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.1.5 ThermoFisher Recent Development
11.2 Abcam
11.2.1 Abcam Company Details
11.2.2 Abcam Business Overview
11.2.3 Abcam Monoclonal Antibody Development and Production Service Introduction
11.2.4 Abcam Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.2.5 Abcam Recent Development
11.3 BICO
11.3.1 BICO Company Details
11.3.2 BICO Business Overview
11.3.3 BICO Monoclonal Antibody Development and Production Service Introduction
11.3.4 BICO Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.3.5 BICO Recent Development
11.4 Rockland
11.4.1 Rockland Company Details
11.4.2 Rockland Business Overview
11.4.3 Rockland Monoclonal Antibody Development and Production Service Introduction
11.4.4 Rockland Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.4.5 Rockland Recent Development
11.5 ProSci
11.5.1 ProSci Company Details
11.5.2 ProSci Business Overview
11.5.3 ProSci Monoclonal Antibody Development and Production Service Introduction
11.5.4 ProSci Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.5.5 ProSci Recent Development
11.6 Biocompare
11.6.1 Biocompare Company Details
11.6.2 Biocompare Business Overview
11.6.3 Biocompare Monoclonal Antibody Development and Production Service Introduction
11.6.4 Biocompare Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.6.5 Biocompare Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Monoclonal Antibody Development and Production Service Introduction
11.7.4 Bio-Rad Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.7.5 Bio-Rad Recent Development
11.8 Evitria AG
11.8.1 Evitria AG Company Details
11.8.2 Evitria AG Business Overview
11.8.3 Evitria AG Monoclonal Antibody Development and Production Service Introduction
11.8.4 Evitria AG Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.8.5 Evitria AG Recent Development
11.9 Capra Science
11.9.1 Capra Science Company Details
11.9.2 Capra Science Business Overview
11.9.3 Capra Science Monoclonal Antibody Development and Production Service Introduction
11.9.4 Capra Science Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.9.5 Capra Science Recent Development
11.10 Innovagen
11.10.1 Innovagen Company Details
11.10.2 Innovagen Business Overview
11.10.3 Innovagen Monoclonal Antibody Development and Production Service Introduction
11.10.4 Innovagen Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.10.5 Innovagen Recent Development
11.11 Life Science Group
11.11.1 Life Science Group Company Details
11.11.2 Life Science Group Business Overview
11.11.3 Life Science Group Monoclonal Antibody Development and Production Service Introduction
11.11.4 Life Science Group Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.11.5 Life Science Group Recent Development
11.12 Randox
11.12.1 Randox Company Details
11.12.2 Randox Business Overview
11.12.3 Randox Monoclonal Antibody Development and Production Service Introduction
11.12.4 Randox Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.12.5 Randox Recent Development
11.13 Davids Biotechnologie
11.13.1 Davids Biotechnologie Company Details
11.13.2 Davids Biotechnologie Business Overview
11.13.3 Davids Biotechnologie Monoclonal Antibody Development and Production Service Introduction
11.13.4 Davids Biotechnologie Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.13.5 Davids Biotechnologie Recent Development
11.14 Abgent
11.14.1 Abgent Company Details
11.14.2 Abgent Business Overview
11.14.3 Abgent Monoclonal Antibody Development and Production Service Introduction
11.14.4 Abgent Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.14.5 Abgent Recent Development
11.15 InVivo BioTech Services
11.15.1 InVivo BioTech Services Company Details
11.15.2 InVivo BioTech Services Business Overview
11.15.3 InVivo BioTech Services Monoclonal Antibody Development and Production Service Introduction
11.15.4 InVivo BioTech Services Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.15.5 InVivo BioTech Services Recent Development
11.16 BioGenes
11.16.1 BioGenes Company Details
11.16.2 BioGenes Business Overview
11.16.3 BioGenes Monoclonal Antibody Development and Production Service Introduction
11.16.4 BioGenes Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.16.5 BioGenes Recent Development
11.17 Helmholtz Zentrum München
11.17.1 Helmholtz Zentrum München Company Details
11.17.2 Helmholtz Zentrum München Business Overview
11.17.3 Helmholtz Zentrum München Monoclonal Antibody Development and Production Service Introduction
11.17.4 Helmholtz Zentrum München Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.17.5 Helmholtz Zentrum München Recent Development
11.18 Kaneka Eurogentec
11.18.1 Kaneka Eurogentec Company Details
11.18.2 Kaneka Eurogentec Business Overview
11.18.3 Kaneka Eurogentec Monoclonal Antibody Development and Production Service Introduction
11.18.4 Kaneka Eurogentec Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.18.5 Kaneka Eurogentec Recent Development
11.19 Beijing Abace Biology
11.19.1 Beijing Abace Biology Company Details
11.19.2 Beijing Abace Biology Business Overview
11.19.3 Beijing Abace Biology Monoclonal Antibody Development and Production Service Introduction
11.19.4 Beijing Abace Biology Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.19.5 Beijing Abace Biology Recent Development
11.20 Beijing Sino Biological
11.20.1 Beijing Sino Biological Company Details
11.20.2 Beijing Sino Biological Business Overview
11.20.3 Beijing Sino Biological Monoclonal Antibody Development and Production Service Introduction
11.20.4 Beijing Sino Biological Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.20.5 Beijing Sino Biological Recent Development
11.21 Nanjing GenScript Biotechnology
11.21.1 Nanjing GenScript Biotechnology Company Details
11.21.2 Nanjing GenScript Biotechnology Business Overview
11.21.3 Nanjing GenScript Biotechnology Monoclonal Antibody Development and Production Service Introduction
11.21.4 Nanjing GenScript Biotechnology Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.21.5 Nanjing GenScript Biotechnology Recent Development
11.22 Shanghai Sangon Biotech
11.22.1 Shanghai Sangon Biotech Company Details
11.22.2 Shanghai Sangon Biotech Business Overview
11.22.3 Shanghai Sangon Biotech Monoclonal Antibody Development and Production Service Introduction
11.22.4 Shanghai Sangon Biotech Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.22.5 Shanghai Sangon Biotech Recent Development
11.23 Nanjing Zoonbio Biotechnology
11.23.1 Nanjing Zoonbio Biotechnology Company Details
11.23.2 Nanjing Zoonbio Biotechnology Business Overview
11.23.3 Nanjing Zoonbio Biotechnology Monoclonal Antibody Development and Production Service Introduction
11.23.4 Nanjing Zoonbio Biotechnology Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.23.5 Nanjing Zoonbio Biotechnology Recent Development
11.24 Suzhou Synbio Technologies
11.24.1 Suzhou Synbio Technologies Company Details
11.24.2 Suzhou Synbio Technologies Business Overview
11.24.3 Suzhou Synbio Technologies Monoclonal Antibody Development and Production Service Introduction
11.24.4 Suzhou Synbio Technologies Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025)
11.24.5 Suzhou Synbio Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibody Development and Production Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Human Monoclonal Antibodies
Table 3. Key Players of Mouse Monoclonal Antibodies
Table 4. Key Players of Others
Table 5. Global Monoclonal Antibody Development and Production Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Monoclonal Antibody Development and Production Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Monoclonal Antibody Development and Production Service Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Monoclonal Antibody Development and Production Service Market Share by Region (2020-2025)
Table 9. Global Monoclonal Antibody Development and Production Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Monoclonal Antibody Development and Production Service Market Share by Region (2026-2031)
Table 11. Monoclonal Antibody Development and Production Service Market Trends
Table 12. Monoclonal Antibody Development and Production Service Market Drivers
Table 13. Monoclonal Antibody Development and Production Service Market Challenges
Table 14. Monoclonal Antibody Development and Production Service Market Restraints
Table 15. Global Monoclonal Antibody Development and Production Service Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Monoclonal Antibody Development and Production Service Market Share by Players (2020-2025)
Table 17. Global Top Monoclonal Antibody Development and Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Development and Production Service as of 2024)
Table 18. Ranking of Global Top Monoclonal Antibody Development and Production Service Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Monoclonal Antibody Development and Production Service Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Monoclonal Antibody Development and Production Service, Headquarters and Area Served
Table 21. Global Key Players of Monoclonal Antibody Development and Production Service, Product and Application
Table 22. Global Key Players of Monoclonal Antibody Development and Production Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Monoclonal Antibody Development and Production Service Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Monoclonal Antibody Development and Production Service Revenue Market Share by Type (2020-2025)
Table 26. Global Monoclonal Antibody Development and Production Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Monoclonal Antibody Development and Production Service Revenue Market Share by Type (2026-2031)
Table 28. Global Monoclonal Antibody Development and Production Service Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Monoclonal Antibody Development and Production Service Revenue Market Share by Application (2020-2025)
Table 30. Global Monoclonal Antibody Development and Production Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Monoclonal Antibody Development and Production Service Revenue Market Share by Application (2026-2031)
Table 32. North America Monoclonal Antibody Development and Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Monoclonal Antibody Development and Production Service Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Monoclonal Antibody Development and Production Service Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Monoclonal Antibody Development and Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Monoclonal Antibody Development and Production Service Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Monoclonal Antibody Development and Production Service Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Monoclonal Antibody Development and Production Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Monoclonal Antibody Development and Production Service Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Monoclonal Antibody Development and Production Service Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Monoclonal Antibody Development and Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Monoclonal Antibody Development and Production Service Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Monoclonal Antibody Development and Production Service Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Monoclonal Antibody Development and Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Monoclonal Antibody Development and Production Service Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Monoclonal Antibody Development and Production Service Market Size by Country (2026-2031) & (US$ Million)
Table 47. ThermoFisher Company Details
Table 48. ThermoFisher Business Overview
Table 49. ThermoFisher Monoclonal Antibody Development and Production Service Product
Table 50. ThermoFisher Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 51. ThermoFisher Recent Development
Table 52. Abcam Company Details
Table 53. Abcam Business Overview
Table 54. Abcam Monoclonal Antibody Development and Production Service Product
Table 55. Abcam Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 56. Abcam Recent Development
Table 57. BICO Company Details
Table 58. BICO Business Overview
Table 59. BICO Monoclonal Antibody Development and Production Service Product
Table 60. BICO Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 61. BICO Recent Development
Table 62. Rockland Company Details
Table 63. Rockland Business Overview
Table 64. Rockland Monoclonal Antibody Development and Production Service Product
Table 65. Rockland Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 66. Rockland Recent Development
Table 67. ProSci Company Details
Table 68. ProSci Business Overview
Table 69. ProSci Monoclonal Antibody Development and Production Service Product
Table 70. ProSci Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 71. ProSci Recent Development
Table 72. Biocompare Company Details
Table 73. Biocompare Business Overview
Table 74. Biocompare Monoclonal Antibody Development and Production Service Product
Table 75. Biocompare Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 76. Biocompare Recent Development
Table 77. Bio-Rad Company Details
Table 78. Bio-Rad Business Overview
Table 79. Bio-Rad Monoclonal Antibody Development and Production Service Product
Table 80. Bio-Rad Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 81. Bio-Rad Recent Development
Table 82. Evitria AG Company Details
Table 83. Evitria AG Business Overview
Table 84. Evitria AG Monoclonal Antibody Development and Production Service Product
Table 85. Evitria AG Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 86. Evitria AG Recent Development
Table 87. Capra Science Company Details
Table 88. Capra Science Business Overview
Table 89. Capra Science Monoclonal Antibody Development and Production Service Product
Table 90. Capra Science Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 91. Capra Science Recent Development
Table 92. Innovagen Company Details
Table 93. Innovagen Business Overview
Table 94. Innovagen Monoclonal Antibody Development and Production Service Product
Table 95. Innovagen Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 96. Innovagen Recent Development
Table 97. Life Science Group Company Details
Table 98. Life Science Group Business Overview
Table 99. Life Science Group Monoclonal Antibody Development and Production Service Product
Table 100. Life Science Group Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 101. Life Science Group Recent Development
Table 102. Randox Company Details
Table 103. Randox Business Overview
Table 104. Randox Monoclonal Antibody Development and Production Service Product
Table 105. Randox Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 106. Randox Recent Development
Table 107. Davids Biotechnologie Company Details
Table 108. Davids Biotechnologie Business Overview
Table 109. Davids Biotechnologie Monoclonal Antibody Development and Production Service Product
Table 110. Davids Biotechnologie Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 111. Davids Biotechnologie Recent Development
Table 112. Abgent Company Details
Table 113. Abgent Business Overview
Table 114. Abgent Monoclonal Antibody Development and Production Service Product
Table 115. Abgent Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 116. Abgent Recent Development
Table 117. InVivo BioTech Services Company Details
Table 118. InVivo BioTech Services Business Overview
Table 119. InVivo BioTech Services Monoclonal Antibody Development and Production Service Product
Table 120. InVivo BioTech Services Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 121. InVivo BioTech Services Recent Development
Table 122. BioGenes Company Details
Table 123. BioGenes Business Overview
Table 124. BioGenes Monoclonal Antibody Development and Production Service Product
Table 125. BioGenes Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 126. BioGenes Recent Development
Table 127. Helmholtz Zentrum München Company Details
Table 128. Helmholtz Zentrum München Business Overview
Table 129. Helmholtz Zentrum München Monoclonal Antibody Development and Production Service Product
Table 130. Helmholtz Zentrum München Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 131. Helmholtz Zentrum München Recent Development
Table 132. Kaneka Eurogentec Company Details
Table 133. Kaneka Eurogentec Business Overview
Table 134. Kaneka Eurogentec Monoclonal Antibody Development and Production Service Product
Table 135. Kaneka Eurogentec Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 136. Kaneka Eurogentec Recent Development
Table 137. Beijing Abace Biology Company Details
Table 138. Beijing Abace Biology Business Overview
Table 139. Beijing Abace Biology Monoclonal Antibody Development and Production Service Product
Table 140. Beijing Abace Biology Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 141. Beijing Abace Biology Recent Development
Table 142. Beijing Sino Biological Company Details
Table 143. Beijing Sino Biological Business Overview
Table 144. Beijing Sino Biological Monoclonal Antibody Development and Production Service Product
Table 145. Beijing Sino Biological Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 146. Beijing Sino Biological Recent Development
Table 147. Nanjing GenScript Biotechnology Company Details
Table 148. Nanjing GenScript Biotechnology Business Overview
Table 149. Nanjing GenScript Biotechnology Monoclonal Antibody Development and Production Service Product
Table 150. Nanjing GenScript Biotechnology Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 151. Nanjing GenScript Biotechnology Recent Development
Table 152. Shanghai Sangon Biotech Company Details
Table 153. Shanghai Sangon Biotech Business Overview
Table 154. Shanghai Sangon Biotech Monoclonal Antibody Development and Production Service Product
Table 155. Shanghai Sangon Biotech Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 156. Shanghai Sangon Biotech Recent Development
Table 157. Nanjing Zoonbio Biotechnology Company Details
Table 158. Nanjing Zoonbio Biotechnology Business Overview
Table 159. Nanjing Zoonbio Biotechnology Monoclonal Antibody Development and Production Service Product
Table 160. Nanjing Zoonbio Biotechnology Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 161. Nanjing Zoonbio Biotechnology Recent Development
Table 162. Suzhou Synbio Technologies Company Details
Table 163. Suzhou Synbio Technologies Business Overview
Table 164. Suzhou Synbio Technologies Monoclonal Antibody Development and Production Service Product
Table 165. Suzhou Synbio Technologies Revenue in Monoclonal Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 166. Suzhou Synbio Technologies Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
Table 170. Authors List of This Report
List of Figures
Figure 1. Monoclonal Antibody Development and Production Service Picture
Figure 2. Global Monoclonal Antibody Development and Production Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Monoclonal Antibody Development and Production Service Market Share by Type: 2024 VS 2031
Figure 4. Human Monoclonal Antibodies Features
Figure 5. Mouse Monoclonal Antibodies Features
Figure 6. Others Features
Figure 7. Global Monoclonal Antibody Development and Production Service Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Monoclonal Antibody Development and Production Service Market Share by Application: 2024 VS 2031
Figure 9. Medical Case Studies
Figure 10. Pharmaceutical Case Studies
Figure 11. Scientific Research Case Studies
Figure 12. Monoclonal Antibody Development and Production Service Report Years Considered
Figure 13. Global Monoclonal Antibody Development and Production Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Monoclonal Antibody Development and Production Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Monoclonal Antibody Development and Production Service Market Share by Region: 2024 VS 2031
Figure 16. Global Monoclonal Antibody Development and Production Service Market Share by Players in 2024
Figure 17. Global Monoclonal Antibody Development and Production Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibody Development and Production Service Revenue in 2024
Figure 19. North America Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Monoclonal Antibody Development and Production Service Market Share by Country (2020-2031)
Figure 21. United States Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Monoclonal Antibody Development and Production Service Market Share by Country (2020-2031)
Figure 25. Germany Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Monoclonal Antibody Development and Production Service Market Share by Region (2020-2031)
Figure 33. China Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Monoclonal Antibody Development and Production Service Market Share by Country (2020-2031)
Figure 41. Mexico Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Monoclonal Antibody Development and Production Service Market Share by Country (2020-2031)
Figure 45. Turkey Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Monoclonal Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. ThermoFisher Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 49. Abcam Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 50. BICO Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 51. Rockland Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 52. ProSci Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 53. Biocompare Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 54. Bio-Rad Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 55. Evitria AG Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 56. Capra Science Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 57. Innovagen Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 58. Life Science Group Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 59. Randox Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 60. Davids Biotechnologie Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 61. Abgent Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 62. InVivo BioTech Services Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 63. BioGenes Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 64. Helmholtz Zentrum München Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 65. Kaneka Eurogentec Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 66. Beijing Abace Biology Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 67. Beijing Sino Biological Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 68. Nanjing GenScript Biotechnology Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 69. Shanghai Sangon Biotech Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 70. Nanjing Zoonbio Biotechnology Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 71. Suzhou Synbio Technologies Revenue Growth Rate in Monoclonal Antibody Development and Production Service Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
